These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 15771236)

  • 21. A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.
    Poulin P
    Clin Pharmacokinet; 2011 Oct; 50(10):665-74. PubMed ID: 21895038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance.
    Nagilla R; Frank KA; Jolivette LJ; Ward KW
    J Pharmacol Toxicol Methods; 2006; 53(2):106-16. PubMed ID: 16188462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view.
    Hallifax D; Foster JA; Houston JB
    Pharm Res; 2010 Oct; 27(10):2150-61. PubMed ID: 20661765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative assessment of empirical and physiological approaches on predicting human clearances.
    Tamaki S; Komura H; Kogayu M; Yamada S
    J Pharm Sci; 2011 Mar; 100(3):1147-55. PubMed ID: 20830811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs.
    Hallifax D; Houston JB
    J Pharm Sci; 2012 Aug; 101(8):2645-52. PubMed ID: 22700322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance.
    Brown HS; Griffin M; Houston JB
    Drug Metab Dispos; 2007 Feb; 35(2):293-301. PubMed ID: 17132764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of hepatic metabolic clearance: comparison and assessment of prediction models.
    Zuegge J; Schneider G; Coassolo P; Lavé T
    Clin Pharmacokinet; 2001; 40(7):553-63. PubMed ID: 11510631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
    Zanelli U; Caradonna NP; Hallifax D; Turlizzi E; Houston JB
    Drug Metab Dispos; 2012 Jan; 40(1):104-10. PubMed ID: 21998403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
    Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
    Wan H; Bold P; Larsson LO; Ulander J; Peters S; Löfberg B; Ungell AL; Någård M; Llinàs A
    Curr Drug Metab; 2010 Sep; 11(7):583-94. PubMed ID: 20629632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.
    Carlile DJ; Zomorodi K; Houston JB
    Drug Metab Dispos; 1997 Aug; 25(8):903-11. PubMed ID: 9280396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of human drug clearance from two species: a comparison of several allometric methods.
    Goteti K; Garner CE; Mahmood I
    J Pharm Sci; 2010 Mar; 99(3):1601-13. PubMed ID: 19827101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions.
    Stringer RA; Strain-Damerell C; Nicklin P; Houston JB
    Drug Metab Dispos; 2009 May; 37(5):1025-34. PubMed ID: 19196847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative prediction of intestinal metabolism in humans from a simplified intestinal availability model and empirical scaling factor.
    Kadono K; Akabane T; Tabata K; Gato K; Terashita S; Teramura T
    Drug Metab Dispos; 2010 Jul; 38(7):1230-7. PubMed ID: 20354105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.
    Li XQ; Björkman A; Andersson TB; Gustafsson LL; Masimirembwa CM
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):429-42. PubMed ID: 12920490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Clearance with Simple and Permeability-Limited Physiologically Based Pharmacokinetic Frameworks: Comparison of Well-Stirred, Dispersion, and Parallel-Tube Liver Models.
    Nagar S; Parise R; Korzekwa K
    Drug Metab Dispos; 2024 Sep; 52(10):1060-1072. PubMed ID: 39084881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting oral clearance in humans: how close can we get with allometry?
    Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE
    Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical and theoretical approaches for the prediction of human hepatic clearance using chimeric mice with humanised liver: the use of physiologically based scaling, a novel solution for potential overprediction due to coexisting mouse metabolism.
    Matsumoto S; Kamimura H; Nishiwaki M; Cho N; Kato K; Yamamoto T
    Xenobiotica; 2021 Sep; 51(9):983-994. PubMed ID: 34227923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.